Clinical Trial

Efficacy of Mobile-delivered Sleep Restriction Therapy for Treatment of Insomnia Disorder: Randomised Controlled Trial

Study acronym: SleepFix
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The "SleepFix Study" is a clinical trial designed to evaluate the efficacy of mobile-delivered sleep restriction therapy (dBTi) in comparison to digital sleep health education (control) for treating insomnia disorder in adults aged 18 and above. The study is conducted entirely online, with 558 participants (279 in each group) and aims to determine the impact of the interventions on insomnia symptom severity, sleep metrics, subjective sleep quality, fatigue, anxiety, depressive symptoms, quality of life, medication usage, and workforce productivity.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-10-29; most recent amendment 2024-07-14.
Trial Details
NCT Number NCT06114901
Lead Sponsor Woolcock Institute of Medical Research
Conditions Insomnia
Enrollment 558 participants
Start Date 2025-02-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2028-10-26 (estimated)
Updated on ClinicalTrials.gov 2024-07-16